3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
4
Oropharyngeal Neoplasms
3
Laryngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Mouth Neoplasms
2
Mesothelioma
2
Hypopharyngeal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Interventions
Biopsy
5
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
larotrectinib
2
erdafitinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
palbociclib
1
olaparib
1
niraparib
1
ivosidenib
1
elacestrant
1
alectinib
1
abemaciclib
1
Vincristine
1
Vinblastine
1
Vemurafenib
1
Temozolomide
1
RAD1901
1
Paclitaxel
1
Methotrexate
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.